Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huaier Granule adjuvant therapy trial in stage II-III triple-negative breast cancer with lymph node metastasis
ChiCTR1800015390Phase 4Suspended
- Sponsor
- The First Affiliated Hospital, Anhui Medical University
- Start
- Jan 2018
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of huaier granule in triple-negative breast cancer (TNBC) (2 arms), sponsored by The First Affiliated Hospital, Anhui Medical University. Primary endpoint: Disease-free survival. Started Jan 2018; status: suspended.
02
Drugs
huaier granule
03
Conditions
triple-negative breast cancer (TNBC)
Beyond the preview
Go deeper on ChiCTR1800015390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800015390.